Overview
Graft-versus-host disease (GVHD) is a complication that can
occur after a stem cell or bone marrow transplant in which the newly
transplanted donor cells attack the transplant recipient's body. Symptoms
include abdominal pain or cramps, nausea, vomiting, and diarrhea, dry or
irritated eyes, jaundice, shortness of breath, vaginal dryness and weight loss.
Treatment includes immunosuppressants.
Click here
for sample report @ http://www.wiseguyreports.com/sample-request/1248519-graft-versus-host-disease-gvhd-pipeline-review-h1-2017
Graft Versus Host Disease (GVHD)
Industry Major Outlook
The Pharmaceutical and Healthcare latest pipeline guide Graft
Versus Host Disease (GVHD) – Pipeline Review, H1 2017, provides comprehensive
information on the therapeutics under development for Graft Versus Host Disease
(GVHD) (Immunology), complete with analysis by stage of development, drug
target, mechanism of action (MoA), route of administration (RoA) and molecule
type. The guide covers the descriptive pharmacological action of the
therapeutics, its complete research and development history and latest news and
press releases.
The Graft Versus Host Disease (GVHD) (Immunology) pipeline
guide also reviews of key players involved in therapeutic development for Graft
Versus Host Disease (GVHD) and features dormant and discontinued projects. The
guide covers therapeutics under Development by Companies /Universities
/Institutes, the molecules developed by Companies in Pre-Registration, Filing
rejected/Withdrawn, Phase III, Phase II, Phase I, Preclinical, Discovery and
Unknown stages are 1, 1, 7, 23, 11, 35, 7 and 3 respectively. Similarly, the
Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages
comprises 1, 3, 13 and 2 molecules, respectively.
Graft Versus Host Disease (GVHD) (Immunology) pipeline guide
helps in identifying and tracking emerging players in the market and their
portfolios, enhances decision making capabilities and helps to create effective
counter strategies to gain competitive advantage. Additionally, various dynamic
tracking processes ensure that the most recent developments are captured on a
real time basis.
Scope
- The pipeline guide provides a snapshot of the global
therapeutic landscape of Graft Versus Host Disease (GVHD) (Immunology).
- The pipeline guide reviews pipeline therapeutics for Graft Versus Host Disease (GVHD) (Immunology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide reviews pipeline therapeutics for Graft Versus Host Disease (GVHD) (Immunology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
Reasons to
buy
- Procure strategically important competitor information,
analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Graft Versus Host Disease (GVHD) (Immunology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Graft Versus Host Disease (GVHD) (Immunology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
Table of
Contents
Table of Contents 2
Introduction 5
Graft Versus Host Disease (GVHD) - Overview 6
Graft Versus Host Disease (GVHD) - Therapeutics Development 7
Graft Versus Host Disease (GVHD) - Therapeutics Assessment 22
Graft Versus Host Disease (GVHD) - Companies Involved in Therapeutics Development 34
Graft Versus Host Disease (GVHD) - Drug Profiles 65
Graft Versus Host Disease (GVHD) - Dormant Projects 369
Graft Versus Host Disease (GVHD) - Discontinued Products 373
Graft Versus Host Disease (GVHD) - Product Development Milestones 374
Appendix 385
Table of Contents 2
Introduction 5
Graft Versus Host Disease (GVHD) - Overview 6
Graft Versus Host Disease (GVHD) - Therapeutics Development 7
Graft Versus Host Disease (GVHD) - Therapeutics Assessment 22
Graft Versus Host Disease (GVHD) - Companies Involved in Therapeutics Development 34
Graft Versus Host Disease (GVHD) - Drug Profiles 65
Graft Versus Host Disease (GVHD) - Dormant Projects 369
Graft Versus Host Disease (GVHD) - Discontinued Products 373
Graft Versus Host Disease (GVHD) - Product Development Milestones 374
Appendix 385
…Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1248519-graft-versus-host-disease-gvhd-pipeline-review-h1-2017
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd.
and offers premium progressive statistical surveying, market research reports,
analysis & forecast data for industries and governments around the globe.
Wise Guy Reports understand how essential statistical surveying information is
for your organization or association. Therefore, we have associated with the
top publishers and research firms all specialized in specific domains, ensuring
you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
No comments:
Post a Comment